MyFinsight
Home
Blog
About
Marketable securities
$434,829K
Cash and cash
equivalents
$82,491K
Prepaid expenses and
other current assets
$7,219K
Total property and
equipment
$23,042K
Total current assets
$524,539K
Property and equipment,
net
$15,966K
Operating lease right-of
use assets
$12,230K
Other assets
$3,712K
Restricted cash
equivalents
$1,149K
Less accumulated
depreciation and...
$7,076K
Total assets
$557,596K
Total liabilities,
redeemable convertible...
$557,596K
Total stockholders'
equity (deficit)
$484,838K
Total liabilities
$72,758K
Accumulated deficit
-$199,033K
Accumulated other
comprehensive (loss) income
-$745K
Additional paid-in capital
$684,611K
Total current
liabilities
$32,128K
Deferred revenue, net of
current portion
$30,868K
Operating lease
liabilities, net of current...
$9,762K
Common stock
value-Common Stock
$5K
Deferred revenue,
current portion
$17,339K
Accrued expenses and
other current...
$10,778K
Accounts payable
$2,533K
Operating lease
liabilities, current portion
$1,478K
Back
Back
Balance Sheet
Aktis Oncology, Inc. (AKTS)
Aktis Oncology, Inc. (AKTS)
source: myfinsight.com